Session Category and Theme List
JSHBPS/APHBPA Joint Symposium
【JAJ】Recent trend and perspective of liver transplant
Living-donor and deceased-donor liver transplant is the theme in this symposium. Recent trends of surgical techniques, short- and long-term outcomes, outcomes of ABO-incompatible transplants, and also future perspective of liver transplant are discussed.
Symposium
【SY-1】Simulation and navigation of liver surgery
HBP centers increasingly employ preoperative simulation and intraoperative navigation systems on advanced HBP surgery. These systems most likely result in safe and oncologically precise surgery. Introduction of the recently advanced systems and the clinical results related to such systems would be expected in this session.
【SY-2】Recent treatment strategies for HCC -non-surgical treatment, resection and transplantation-
HCC has been treated by various and/or multidisciplinary strategies. The aim of this session is to know what strategy should be selected for each stage and background of HCC. Presentation of the results from non-surgical treatments including locoregional therapies, anatomical and nonanatomical hepatic resection, and transplantation are expected.
【SY-3】Highly advanced biliary surgery – warranty of good safety
Highly advanced biliary surgery is inherently risky. The patients are frequently complicated with preoperative jaundice and/or cholangitis with contaminated bile, and extended hepatectomy is usually required. The important preoperative preparations, indication of surgery, extent and type of surgery, and optimal postoperative management for warranty of safety are shown in this session.
【SY-4】Best strategy for R and BR pancreas cancer
Adjuvant chemotherapy became the standard and is recommended for patients after resection of pancreas cancer (PDAC) while preoperative treatment has still a controversy for Resectable (R)-PDAC. Moreover, the best strategy for Borderline Resectable (BR)-PDAC remains unclear. Active centers for PDAC surgery demonstrate their strategy and accumulated results.
Mini-Symposium
【MSY-1】Treatment strategies for ampulla of Vater cancer
Ampullary cancer is relatively uncommon. Optimal lymph node dissection and adjuvant chemotherapy remain to be well established. Ampullary cancers can be subdivided into intestinal or pancreatobiliary subtype cancers with histomolecular staining. These subtype cancer have different biological behavior and prognosis. It is hoped that some evidences would be shown in ampullary cancer treatment.
【MSY-2】How to manage bile duct injury
Bile duct injury can occasionally occur during acute / chronic cholecystitis surgery or hepatic hilar dissection for hepatobiliary malignancies. In such cases, precise anatomical identification might be extremely difficult. The speakers are expected to show how to avoid bile duct injury and how to manage at the time of its occurrence.
【MSY-3】ABO incompatible liver transplantation; current status and perspective
Transplantation using ABO incompatible liver grafts is important because it can represent the only access to transplantation for an acutely ill patient when a compatible graft is not available. Japan and Korea have great experiences of ABO incompatible living donor liver transplantation. The major transplant centers are expected to give their strategies to decrease the risk for antibody‐mediated rejection.
【MSY-4】Current status and perspective of pancreatic transplantation
Over 40,000 pancreas transplants have been registered so far in the world and the outcomes have greatly improved. Current status and perspective of pancreatic transplantation are presented by several active transplant centers.
Video Symposium
【VS-1】How to resect multiple bilobar colorectal liver metastases
In recent years, selected patients with multiple bilobar colorectal liver metastases may be rendered resectable using one or two stage hepatectomy with portal vein embolization. However, suitability for resection in patients with complex and extensive hepatic metastases is controversial. The indication and surgical strategy are demonstrated by the high-volume centers.
【VS-2】New technologies to prevent POPF in DP
Distal pancreatectomy (DP) is associated with a high frequency of postoperative pancreatic fistula (POPF) compared to pancreatoduodenectomy. The incidences of around 40% have been reported. It is hoped that excellent, novel or unique techniques to prevent POPF would be presented in this Video Symposium.
【VS-3】Hilar cholangiocarcinoma; up to date
Hilar cholangiocarcinoma surgery is a highly advanced one and carries a risk of serious postoperative complications including liver failure. In particular, left trisectionectomy is associated with relatively high mortality. Perioperative management is also very important for the successful result. The important surgical techniques and accumulated results are presented in this session.
【VS-4】Prevention and troubleshooting for serious technical complications in laparoscopic HBP surgery
Laparoscopic HBP procedure is one of the greatest improvements in surgery within the last decade. However, the introduction of advanced laparoscopic HBP surgery involves some risks of technical complications. This session aims to help surgeons to learn the skills of prevention and troubleshooting for serious technical complications in laparoscopic HBP surgery.
Panel Discussion
【PD-1】Trauma managements and surgery in HBP injuries
Trauma of HBP occasionally leads to life-threatening condition. Optimal management and prompt decision of surgery are needed in patients with serious injury. We welcome presentations of the treatment strategy, indication of surgery, and surgical technology in HBP trauma, which are followed by discussion with the session participants
【PD-2】Best strategy for UR-LA pancreas cancer
Locally advanced unresectable (UR-LA) pancreas cancer may be rendered resectable after recently developed chemotherapy or chemoradiotherapy. However, the best regimen of anticancer drugs, and suitable indication, timing, and resection range of conversion surgery are mostly unknown. In this Panel Discussion, the policy and results are presented by each speaker and discussion of the treatment strategy with audience is followed.
Workshop
【WS-1】Recent advances in treatment strategy for IPMN
Some IPMN have an elevated risk of cancer and require surgical resection, while others are low-risk lesions and can be followed. Several clinical, radiographic, and laboratory parameters have been proposed to risk-stratify IPMN. However, the treatment guidelines do not always converge in their recommendations. Discussion on the treatment strategy is expected in this session.
【WS-2】Herbal medicine in HBP diseases
Several herbal medicines including Daikenchuto, Rikkunsito and Inchinkoto have been empirically used for a patient management before or after HBP surgery. However, more recently, some scientific evidences based on basic and clinical researches have been published. It is hoped that such evidences would be presented in this topic. Researches in progress are also welcome.
【WS-3】Clinicopathological and genetic analyses of HBP malignancies
Clinicopathological and genetic alteration have been increasingly used as prognostic tools and decision-making tools of HBP malignancy treatment. In this workshop, researches clarifying the clinical implications of the genetic status and relationships with clinicopathological features are strongly invited.
【WS-4】Recent results from multicenter collaborative study in HBP
Multicenter collaborative studies are usually associated with the creation of more reliable evidences also in the field of HBP surgery. Such studies regarding HBP surgery are expected to show in this session. Completed as well as ongoing studies are invited to this session regardless of difference in organ and disease.
【WS-5】Optimal assessment of liver functional reserve
Preoperative estimation of liver functional reserve is important in liver surgery. However, no standard method of estimating liver function has been established to date. Comparison of various methods is expected in this session in terms of simplicity, accuracy and reliability.
【WS-6】Impact of adjuvant or neoadjuvant therapy for advanced biliary cancer
Adjuvant therapy for advanced biliary tract cancers has not been established. Moreover, studies evaluating neoadjuvant treatment for this disease are few. It appears essential to explore novel strategies for improving the prognosis. We welcome presentations of multidisciplinary treatment for biliary tract cancer.
【WS-7】Up-to-date strategy for PNET surgery
The surgical strategy for pancreatic neuroendocrine tumor (PNET) has not been standardized. Indication of resection and extent of lymphadenectomy differ among centers and countries. Additionally, minimal invasive surgery is recommended for some PNETs. The optimal treatment strategies depending on tumor size, location and types are discussed in this topic.
【WS-8】Postoperative states and appropriate managements of patients undergoing total pancreatectomy
Postoperative glucose control, nutritional status, and quality of life after total pancreatectomy have gradually improved with the development of long-acting insulin and effective digestive enzymes. Thus, frequency of total pancreatectomy has increased over the last two decades. The postoperative states and appropriate managements are shown and discussed in this session.
